查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530033

乳房病变定位市场规模、份额、趋势分析报告：按类型、地区、细分市场预测，2024-2030 年

Breast Lesion Localization Methods Market Size, Share & Trends Analysis Report By Type (Wire Guided Localization, Radioisotope Localization, Magnetic Tracer, & Others), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

乳房病变定位市场成长与趋势：

Grand View Research, Inc.最新报告预测，到2030年，全球乳房病变定位市场规模预计将达到36.2亿美元，2024年至2030年复合年增长率为7.8%。预计政府和非政府对乳癌诊断、切片检查、测试和相关医疗程序的报销政策的增加将推动乳房病变定位方法的采用。此外，由于女性乳癌发病率上升，对改善医疗基础设施和设施的需求不断增长，预计将推动市场成长。

随着女性乳癌发生率的增加，对准确、早期检测方法的需求也随之增加。乳房病变定位技术对于准确识别可疑病变并针对其进行切片检查或手术干预至关重要。例如，根据美国国家乳癌基金会2024年4月的报告，美国八分之一的女性在一生中将被诊断出罹患乳癌。到 2024 年，预计将有约 310,720 名女性和 2,800 名男性被诊断出患有侵袭性乳癌。乳癌盛行率的增加引起了人们对客製化治疗策略的关注。先进的病灶定位技术可以帮助肿瘤科医师和外科医师制定和实施详细的治疗计划，为患者实现最佳结果。这些因素推动了对乳房病变定位方法的需求。

数位乳房X光摄影、超音波和MRI等影像技术的进步极大地改善了乳房病变的检测和表征。因此，对精确定位技术来准确指导外科手术的需求日益增长。此外，3D显像模式和导航系统的整合使外科医生能够在手术过程中即时可视化乳房病变的位置，从而显着提高手术准确性并改善患者的治疗效果。这些因素正在推动预测期内的市场成长。

乳房病变定位市场报告亮点：

  • 按产品类型划分，由于产品种类繁多且最终用户对该技术的采用率很高，因此到 2023 年，线导立体定位技术将占据最大的市场占有率。
  • 基于放射性同位素的乳房定位预计在预测期内将出现显着增长，因为它有效、安全且广泛用于术前定位不可触及的可疑乳房病变。
  • 由于该地区主要製造商的存在、成熟的医疗基础设施以及引进本地化设备的进展，北美地区将在 2023 年拥有最高的销售份额并主导市场。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章乳房病变定位方法的市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 乳房病灶定位方法市场分析工具
    • 波特五力分析
    • PESTEL分析

第四章乳房病变定位市场：按类型估计和趋势分析

  • 细分仪表板
  • 全球乳房病变定位方法市场：类型变异分析，百万美元，数量单位，2023 年和 2030 年
  • 2018-2030年全球乳房病变定位方法市场规模及趋势分析（依类型）
  • 找到导线器
  • 放射性同位素定位
  • 磁示踪剂
  • 其他的

第五章乳房病变定位市场：区域、估计与趋势分析

  • 区域仪表板
  • 2018-2030年市场规模及趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第六章 竞争状况

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 2023 年企业市场占有率分析
  • 企业热力图分析
  • 策略规划
    • 扩张
    • 併购
    • 伙伴关係与协作
    • 新产品发布
    • 研究与开发
    • 公司简介
    • BD
    • SOMATEX Medical Technologies GmbH
    • Argon Medical Devices
    • Merit Medical Systems
    • Cook Medical
    • STERYLAB Srl
    • Theragenics Corporation
    • MDL SRL
    • MOLLI Surgical
    • Mermaid Medical
    • IsoAid
    • Intramedical Imaging, LLC
Product Code: GVR-1-68038-958-6

Breast Lesion Localization Methods Market Growth & Trends:

The global breast lesion localization methods market size is anticipated to reach USD 3.62 billion by 2030 and is anticipated to grow at a CAGR of 7.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing government and non-government reimbursement policies for breast cancer diagnostics, biopsies, examinations, and related medical procedures are projected to drive adoption of breast lesion localization methods. Furthermore, the growing demand for improved healthcare infrastructure and facilities, driven by the rising prevalence of the disease among women, is anticipated to boost the market growth.

As the incidence of breast cancer among women rises, there is a heightened need for precise and early detection methods. Breast lesion localization techniques are pivotal in accurately identifying and targeting suspicious lesions for biopsy or surgical intervention. For instance, As per a report by National Breast Cancer Foundation, Inc., in April 2024, approximately 1 out of every 8 women in the U.S. will receive a breast cancer diagnosis during her lifetime. In 2024, it is projected that around 310,720 women and 2,800 men will be diagnosed with invasive breast cancer. With the increasing prevalence of breast cancer, there is a growing focus on tailored treatment strategies. Advanced lesion localization methods empower oncologists and surgeons to meticulously plan and deliver treatments, aiming for the best possible patient outcomes. These factors are driving the demand for breast lesions localizations methods.

Advancements in imaging technologies like digital mammography, ultrasound, and MRI have greatly improved the detection and characterization of breast lesions. As a result, there is an increased need for precise localization techniques to guide surgical procedures accurately. Furthermore, the integration of 3D imaging modalities and navigation systems allows surgeons to visualize breast lesion locations in real-time during procedures, significantly enhancing surgical precision and improving patient outcomes. These factors are propelling the market growth over the forecast period.

Breast Lesion Localization Methods Market Report Highlights:

  • Based on type, the wire-guided localization segment held the largest market share in 2023 owing to the presence of a wide range of products and high adoption of this technique among end-users.
  • Radioisotope localization is expected to witness significant growth over the forecast period as it is an effective, safe, and widely used procedure for preoperative localization of non-palpable, suspicious breast lesions.
  • North America dominated the market with the highest revenue share in 2023 owing to the presence of key manufacturers in the region, established healthcare infrastructure, and high adoption of localization devices.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Breast Lesion Localization Methods Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising prevalence of breast cancer among women
      • 3.2.1.2. Increasing awareness through cancer screening programs
      • 3.2.1.3. Technological advancements
      • 3.2.1.4. Availability of various techniques
      • 3.2.1.5. Demand for minimally invasive and accurate procedures
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Risk associated with breast localization methods
      • 3.2.2.2. Presence of complicated regulatory framework
  • 3.3. Breast Lesion Localization Methods Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Breast Lesion Localization Methods Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Breast Lesion Localization Methods Market: Type Movement Analysis, USD Million, Volume Unit, 2023 & 2030
  • 4.3. Global Breast Lesion Localization Methods Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million, Volume Unit,)
  • 4.4. Wire Guided Localization
    • 4.4.1. Wire guided localization market revenue estimates and forecasts, 2018 - 2030 (USD Million, Volume Unit)
  • 4.5. Radioisotope Localization
    • 4.5.1. Radioisotope localization market revenue estimates and forecasts, 2018 - 2030 (USD million)
    • 4.5.2. Radio guided occult-lesion localization (ROLL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
      • 4.5.2.1. Radio Guided occult-lesion localization (ROLL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
    • 4.5.3. Radio guided occult-lesion localization (ROLL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
      • 4.5.3.1. Radio Guided occult-lesion localization (ROLL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
    • 4.5.4. Radioactive-seed localization (RSL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
      • 4.5.4.1. Radioactive-seed localization (RSL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
    • 4.5.5. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
      • 4.5.5.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.6. Magnetic Tracer
    • 4.6.1. Magnetic tracer market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.7. Others
    • 4.7.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million, Volume Unit)

Chapter 5. Breast Lesion Localization Methods Market: Regional Estimates & Trend Analysis by Type

  • 5.1. Regional Dashboard
  • 5.2. Market Size and Trend Analysis, 2018 to 2030
  • 5.3. North America
    • 5.3.1. North America breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Competitive scenario
      • 5.3.2.3. Regulatory framework
      • 5.3.2.4. Reimbursement scenario
      • 5.3.2.5. U.S. breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Competitive scenario
      • 5.3.3.3. Regulatory framework
      • 5.3.3.4. Reimbursement scenario
      • 5.3.3.5. Canada breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key country dynamics
      • 5.3.4.2. Competitive scenario
      • 5.3.4.3. Regulatory framework
      • 5.3.4.4. Reimbursement scenario
      • 5.3.4.5. Mexico breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Europe breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Competitive scenario
      • 5.4.2.3. Regulatory framework
      • 5.4.2.4. Reimbursement scenario
      • 5.4.2.5. UK breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Competitive scenario
      • 5.4.3.3. Regulatory framework
      • 5.4.3.4. Reimbursement scenario
      • 5.4.3.5. Germany breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Competitive scenario
      • 5.4.4.3. Regulatory framework
      • 5.4.4.4. Reimbursement scenario
      • 5.4.4.5. France breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Competitive scenario
      • 5.4.5.3. Regulatory framework
      • 5.4.5.4. Reimbursement scenario
      • 5.4.5.5. Italy breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Competitive scenario
      • 5.4.6.3. Regulatory framework
      • 5.4.6.4. Reimbursement scenario
      • 5.4.6.5. Spain breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Competitive scenario
      • 5.4.7.3. Regulatory framework
      • 5.4.7.4. Reimbursement scenario
      • 5.4.7.5. Sweden breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Competitive scenario
      • 5.4.8.3. Regulatory framework
      • 5.4.8.4. Reimbursement scenario
      • 5.4.8.5. Denmark breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.9. Norway
      • 5.4.9.1. Key country dynamics
      • 5.4.9.2. Competitive scenario
      • 5.4.9.3. Regulatory framework
      • 5.4.9.4. Reimbursement scenario
      • 5.4.9.5. Norway breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Competitive scenario
      • 5.5.2.3. Regulatory framework
      • 5.5.2.4. Reimbursement scenario
      • 5.5.2.5. China breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Japan
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Competitive scenario
      • 5.5.3.3. Regulatory framework
      • 5.5.3.4. Reimbursement scenario
      • 5.5.3.5. Japan breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Competitive scenario
      • 5.5.4.3. Regulatory framework
      • 5.5.4.4. Reimbursement scenario
      • 5.5.4.5. India breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. South Korea
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Competitive scenario
      • 5.5.5.3. Regulatory framework
      • 5.5.5.4. Reimbursement scenario
      • 5.5.5.5. South Korea breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Australia
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Competitive scenario
      • 5.5.6.3. Regulatory framework
      • 5.5.6.4. Reimbursement scenario
      • 5.5.6.5. Australia breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Thailand
      • 5.5.7.1. Key country dynamics
      • 5.5.7.2. Competitive scenario
      • 5.5.7.3. Regulatory framework
      • 5.5.7.4. Reimbursement scenario
      • 5.5.7.5. Thailand breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Competitive scenario
      • 5.6.2.3. Regulatory framework
      • 5.6.2.4. Reimbursement scenario
      • 5.6.2.5. Brazil breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Competitive scenario
      • 5.6.3.3. Regulatory framework
      • 5.6.3.4. Reimbursement scenario
      • 5.6.3.5. Argentina breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Middle East and Africa
    • 5.7.1. Middle East and Africa breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Competitive scenario
      • 5.7.2.3. Regulatory framework
      • 5.7.2.4. Reimbursement scenario
      • 5.7.2.5. South Africa breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Saudi Arabia
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Competitive scenario
      • 5.7.3.3. Regulatory framework
      • 5.7.3.4. Reimbursement scenario
      • 5.7.3.5. Saudi Arabia breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Competitive scenario
      • 5.7.4.3. Regulatory framework
      • 5.7.4.4. Reimbursement scenario
      • 5.7.4.5. UAE breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Competitive scenario
      • 5.7.5.3. Regulatory framework
      • 5.7.5.4. Reimbursement scenario
      • 5.7.5.5. Kuwait breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis by Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Market Share Analysis, 2023
  • 6.4. Company Heat Map Analysis
  • 6.5. Strategy Mapping
    • 6.5.1. Expansion
    • 6.5.2. Mergers & Acquisition
    • 6.5.3. Partnerships & Collaborations
    • 6.5.4. New Product Launches
    • 6.5.5. Research And Development
    • 6.5.6. Company Profiles
    • 6.5.7. BD
      • 6.5.7.1. Company overview
      • 6.5.7.2. Financial performance
      • 6.5.7.3. Product Benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. SOMATEX Medical Technologies GmbH
      • 6.5.8.1. Company overview
      • 6.5.8.2. Financial performance
      • 6.5.8.3. Product Benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. Argon Medical Devices
      • 6.5.9.1. Company overview
      • 6.5.9.2. Financial performance
      • 6.5.9.3. Product Benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. Merit Medical Systems
      • 6.5.10.1. Company overview
      • 6.5.10.2. Financial performance
      • 6.5.10.3. Product Benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Cook Medical
      • 6.5.11.1. Company overview
      • 6.5.11.2. Financial performance
      • 6.5.11.3. Product Benchmarking
      • 6.5.11.4. Strategic initiatives
    • 6.5.12. STERYLAB S.r.l.
      • 6.5.12.1. Company overview
      • 6.5.12.2. Financial performance
      • 6.5.12.3. Product Benchmarking
      • 6.5.12.4. Strategic initiatives
    • 6.5.13. Theragenics Corporation
      • 6.5.13.1. Company overview
      • 6.5.13.2. Financial performance
      • 6.5.13.3. Product Benchmarking
      • 6.5.13.4. Strategic initiatives
    • 6.5.14. MDL SRL
      • 6.5.14.1. Company overview
      • 6.5.14.2. Financial performance
      • 6.5.14.3. Product Benchmarking
      • 6.5.14.4. Strategic initiatives
    • 6.5.15. MOLLI Surgical
      • 6.5.15.1. Company overview
      • 6.5.15.2. Financial performance
      • 6.5.15.3. Product Benchmarking
      • 6.5.15.4. Strategic initiatives
    • 6.5.16. Mermaid Medical
      • 6.5.16.1. Company overview
      • 6.5.16.2. Financial performance
      • 6.5.16.3. Product Benchmarking
      • 6.5.16.4. Strategic initiatives
    • 6.5.17. IsoAid
      • 6.5.17.1. Company overview
      • 6.5.17.2. Financial performance
      • 6.5.17.3. Product Benchmarking
      • 6.5.17.4. Strategic initiatives
    • 6.5.18. Intramedical Imaging, LLC
      • 6.5.18.1. Company overview
      • 6.5.18.2. Financial performance
      • 6.5.18.3. Product Benchmarking
      • 6.5.18.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America breast lesion localization methods market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 4 U.S. breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 5 Canada breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 6 Mexico breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 7 Europe breast lesion localization methods market, by region, 2018 - 2030 (USD Million)
  • Table 8 Europe breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 9 Germany breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 10 UK breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 11 lesion localization methods market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 France breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 13 Italy breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 14 Spain breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 15 Denmark breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 16 Sweden breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 17 Norway breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific breast lesion localization methods market, by region, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 20 China breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 21 Japan breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 22 India breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 23 South Korea breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 24 Australia breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 25 Thailand breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 26 Latin America breast lesion localization methods market, by region, 2018 - 2030 (USD Million)
  • Table 27 Latin America breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 28 Brazil breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 29 Argentina breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 30 MEA breast lesion localization methods market, by region, 2018 - 2030 (USD Million)
  • Table 31 MEA breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 32 South Africa breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 33 Saudi Arabia breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 34 UAE breast lesion localization methods market, by type, 2018 - 2030 (USD Million)
  • Table 35 Kuwait breast lesion localization methods market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Breast lesion localization methods market segmentation.
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing.
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot.
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Breast lesion localization methods - market size and growth prospects (USD Million)
  • Fig. 11 Breast lesion localization methods market: Industry Value Chain Analysis
  • Fig. 12 Breast lesion localization methods market: Market Dynamics
  • Fig. 13 Breast lesion localization methods market: PORTER's Five Forces Analysis
  • Fig. 14 Breast lesion localization methods market: PESTEL Analysis
  • Fig. 15 Breast lesion localization methods market share by type, 2023 & 2030 (USD Million)
  • Fig. 16 Breast lesion localization methods market, by type: market share, 2023 & 2030.
  • Fig. 17 Wire guided localization market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 18 Radioisotope localization market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 19 Radio guided occult-lesion localization (ROLL) market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 20 Radioactive-seed localization (RSL) market estimates & forecasts, 2018 - 2030 (Revenue, USD Million, Volume Unit)
  • Fig. 21 Others market estimates & forecasts, 2018 - 2030 (Revenue, USD Million, Volume Unit)
  • Fig. 22 Magnetic tracer market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 23 Others market estimates & forecasts, 2018 - 2030 (Revenue, USD Million)
  • Fig. 24 Regional marketplace: key takeaways
  • Fig. 25 North America breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Canada breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Mexico breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Europe breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 UK breast lesion localization methods market estimates and forecasts, 2018 - 2030,) (USD Million)
  • Fig. 31 Germany breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 France breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Italy breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Spain breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Denmark breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Norway breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific Breast Lesion Localization Methods Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 39 China breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Japan breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 India breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 South Korea breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Australia breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 MEA breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UAE breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Kuwait breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key company categorization
  • Fig. 54 Company market positioning
  • Fig. 55 Key company market share analysis, 2023
  • Fig. 56 Strategic framework